Inventor · disambiguated record
Stephen T. Wrobleski
Also filed as: WROBLESKI STEPHEN · WROBLESKI STEPHEN T
49 granted patents·13 pending applications·709 citations·filing 2000–2025
98Inventor score
Files withBRISTOL MYERS SQUIBB CO49WROBLESKI STEPHEN T5PHARMACOPEIA INC2CHEN BANG-CHI1DHAR T G MURALI1
Top patents by PatentIndex Score
62 records- 0198US6670357B2Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Dec 30, 2003·137 cites·24 claims
- 0297US9505748B2Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responsesBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Nov 29, 2016·53 cites·9 claims
- 0396US11021475B2Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responsesBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jun 1, 2021·8 cites·16 claims
- 0496US10000480B2Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responsesBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jun 19, 2018·20 cites·14 claims
- 0596US7723336B2Fused heterocyclic compounds useful as kinase modulatorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted May 25, 2010·50 cites·16 claims
- 0695US11021462B2Sulfone pyridine alkyl amide-substituted heteroaryl compoundsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jun 1, 2021·6 cites·28 claims
- 0794US11787779B2Sulfone pyridine alkyl amide-substituted heteroaryl compoundsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Oct 17, 2023·2 cites·4 claims
- 0894USRE47929EAmide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responsesBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Apr 7, 2020·19 cites·39 claims
- 0992US10526321B2Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responsesBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jan 7, 2020·6 cites·1 claims
- 1092US9663467B2Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responsesBRISTOL MYERS SQUIBB CO·Filed 2014·Granted May 30, 2017·21 cites·7 claims
- 1192US6653304B2Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseasesBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Nov 25, 2003·62 cites·8 claims
- 1291US6867300B2Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Mar 15, 2005·45 cites·9 claims
- 1390US9987266B2Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responsesBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jun 5, 2018·9 cites·1 claims
- 1490US7759343B2Pyrrolo-triazine aniline compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Jul 20, 2010·11 cites·12 claims
- 1590US7592338B2Pyrazole-amine compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Sep 22, 2009·9 cites·2 claims
- 1690US7253170B2Pyrazole-amine compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Aug 7, 2007·10 cites·10 claims
- 1790US7253174B2N-heterocyclic inhibitors of TNF-α expressionPHARMACOPEIA INC·Filed 2006·Granted Aug 7, 2007·15 cites·8 claims
- 1889US7605273B2Aryl-substituted pyrazole-amide compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Oct 20, 2009·8 cites·14 claims
- 1989US7462616B2Pyrrolo-triazine aniline compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Dec 9, 2008·12 cites·13 claims
- 2089US7390810B2Pyrazole-amine compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Jun 24, 2008·9 cites·17 claims
- 2189US7151113B2Pyrazole-amine compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Dec 19, 2006·19 cites·13 claims
- 2288US9315494B2Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responsesBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Apr 19, 2016·14 cites·11 claims
- 2388US7160883B2Pyrrolo-triazine aniline compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Jan 9, 2007·23 cites·28 claims
- 2487US9540333B2Alkyl amide-substituted pyrimidine compounds useful in the modulation of IL-12, IL-23 and/or IFNαBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jan 10, 2017·11 cites·16 claims
- 2587US7479495B2N-heterocyclic inhibitors of TNF-α expressionPHARMACOPEIA INC·Filed 2005·Granted Jan 20, 2009·11 cites·32 claims
- 2687US7396935B2Aryl-substituted pyrazole-amide compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Jul 8, 2008·15 cites·12 claims
- 2787US2025243193A1Amide-substituted heterocyclic compounds useful as modulators of il-12, il-23 and/or ifn alpha responsesBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 2886US12365667B2Sulfone pyridine alkyl amide-substituted heteroaryl compoundsBRISTOL MYERS SQUIBB CO·Filed 2023·Granted Jul 22, 2025·0 cites·13 claims
- 2986US6906067B2N-heterocyclic inhibitors of TNF-α expressionPHARMACEOPEIA INC·Filed 2001·Granted Jun 14, 2005·35 cites·20 claims
- 3085US8044040B2N-heterocyclic inhibitors of TNF-alpha expressionBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Oct 25, 2011·6 cites·2 claims
- 3184US7414056B2Pyrazole-amide compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Aug 19, 2008·12 cites·13 claims
- 3284US7034151B2Process for preparing pyrrolotriazine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Apr 25, 2006·17 cites·4 claims
- 3383US7211666B2Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted May 1, 2007·12 cites·13 claims
- 3483US2025304555A1Sulfone pyridine alkyl amide-substituted heteroaryl compoundsBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 3582US7253167B2Tricyclic-heteroaryl compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Aug 7, 2007·6 cites·17 claims
- 3677US7943617B2Heterobicyclic compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted May 17, 2011·2 cites·4 claims
- 3777US7935696B2Heterocyclic amide compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted May 3, 2011·2 cites·9 claims
- 3877US7923556B2Phenyl-substituted pyrimidine compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Apr 12, 2011·2 cites·10 claims
- 3976US7943658B2Indole indane amide compounds useful as CB2 agonists and methodBRISTOL MYERS SQUIBB CO·Filed 2008·Granted May 17, 2011·2 cites·14 claims
- 4076US7642257B2Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Jan 5, 2010·2 cites·13 claims
- 4176US2022356180A1Amide-substituted heterocyclic compounds useful as modulators of il-12, il-23 and/or ifn alpha responsesBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 4270US8987268B2Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseasesWROBLESKI STEPHEN T·Filed 2012·Granted Mar 24, 2015·2 cites·14 claims
- 4370US2010016320A1Aryl-substituted pyrazole-amide compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2009·Application pending·0 cites
- 4466US7419978B2Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Sep 2, 2008·2 cites·10 claims
- 4565US2009227567A1Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2009·Application pending·0 cites
- 4664US9221826B2Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseasesWROBLESKI STEPHEN T·Filed 2012·Granted Dec 29, 2015·1 cites·10 claims
- 4762US7388009B2Heteroaryl-substituted pyrrolo-triazine compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Jun 17, 2008·1 cites·20 claims
- 4856US2011098467A1Pyrrolo-triazine aniline compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2010·Application pending·0 cites
- 4954US2010240646A1Pyrrolo-triazine aniline compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2010·Application pending·0 cites
- 5054US2004229877A1Methods of treating p38 kinase-associated conditions with pyrrolotriazine compoundsFiled 2003·Application pending·0 cites
Showing the top 50 of 62 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →